In the case of other diseases, patients and their families have led the charge for more research and put pressure on governments, the pharmaceutical industry, scientists and regulators.
No caso de outras doenças, os pacientes e as famílias foram os responsáveis pela investigação e pressionaram os governos, a indústria farmacêutica, os cientistas e os legisladores.